SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMcbride Regulatory News (MCB)

Share Price Information for Mcbride (MCB)

Share Price is delayed by 15 minutes
Get Live Data
141.60    -24.20 (-14.60%)
Bid:
140.20
Ask:
144.80
Spread: 4.60 (3.281%)
Market Cap: £241.94m
MCB Live PriceLast checked at - London Stock Exchange

Intraday Mcbride Share Chart

AGM Statement

20 Nov 2025 16:40

RNS Number : 4278I
McBride PLC
20 November 2025
 

20 November 2025

 

McBride plc

Result of Annual General Meeting

 

McBride plc (the 'Company') is pleased to announce that at its Annual General Meeting ('AGM') held earlier today, 20 November 2025, all the resolutions put to its shareholders were passed by the requisite majorities. Resolutions 1 to 13 were passed as ordinary resolutions and resolutions 14 to 17 were passed as special resolutions.

 

The results of the poll vote for each resolution are set out below:

 

No 

RESOLUTION

VOTESFOR (incl. discretionary)

FOR (% of votes cast)

VOTESAGAINST

AGAINST (% of votes cast)

TOTAL VOTES CAST

% of ISSUED SHARE CAPITAL  VOTED

VOTESWITHHELD

1

To receive the Company's accounts for the financial year ended 30 June 2025, together with the Directors' reports and the independent auditor's report on those accounts.

85,390,995

99.99%

6,407

0.01%

85,397,402

47.84%

192,027

2

To approve the Directors' Remuneration Report for the financial year ended 30 June 2025 (other than the summary of the Directors' Remuneration Policy included in the Directors' Remuneration Report)

85,260,889

99.64%

310,662

0.36%

85,571,551

47.93%

17,878

3

To declare a final dividend of 3.0 pence per ordinary share in respect of the year ended 30 June 2025.

85,573,374

100.00%

49

0.00%

85,573,423

47.94%

16,006

4

To re‑appoint Jeffrey (Jeff) Nodland as a Director.

81,458,624

95.20%

4,106,496

4.80%

85,565,120

47.93%

24,309

5

To re‑appoint Christopher (Chris) Smith as a Director.

84,087,237

99.95%

42,722

0.05%

84,129,959

47.13%

1,459,470

6

To re-appoint Mark Strickland as a Director.

85,525,958

99.95%

39,162

0.05%

85,565,120

47.93%

24,309

7

To re-appoint Elizabeth (Liz) McMeikan as a Director.

82,486,730

96.40%

3,078,390

3.60%

85,565,120

47.93%

24,309

8

To re-appoint Alastair Murray as a Director.

83,074,042

97.09%

2,491,078

2.91%

85,565,120

47.93%

24,309

9

To re-appoint Regi Aalstad as a Director.

84,387,739

98.68%

1,126,881

1.32%

85,514,620

47.90%

74,809

10

To re-appoint PricewaterhouseCoopers LLP as auditor of the Company.

84,841,426

99.16%

719,871

0.84%

85,561,297

47.93%

28,132

11

To authorise the Audit and Risk Committee to determine the auditor's remuneration.

84,948,619

99.27%

624,153

0.73%

85,572,772

47.94%

16,657

12

To authorise the Company and its subsidiaries to make political donations and incur political expenditure

85,418,741

99.82%

153,461

0.18%

85,572,202

47.93%

17,227

13

To authorise the Directors to allot shares.

85,523,469

99.94%

48,303

0.06%

85,571,772

47.93%

17,657

14

Subject to the passing of Resolution 13, to authorise the Directors to disapply statutory pre-emption rights in respect of the allotment of the Company's equity securities for cash.

85,457,676

99.88%

106,105

0.12%

85,563,781

47.93%

25,648

15

To authorise the Company to make market purchases of its own shares.

85,492,960

99.95%

42,854

0.05%

85,535,814

47.91%

53,615

16

To authorise the Directors to call a general meeting on 14 clear days' notice.

85,439,241

99.84%

133,531

0.16%

85,572,772

47.94%

16,657

17

To approve, amongst other things, the waiver and release of certain claims which the Company may have in relation to certain dividends and certain loans.

83,223,275

99.94%

52,288

0.06%

83,275,563

46.65%

2,312,085

 

 

The Board would like to thank shareholders for their engagement and support ahead of the AGM and throughout the year.

 

Notes:

 

1. Any proxy arrangement which gave discretion to the Chairman has been included in the "For" totals.

2. A "Vote withheld" is not a vote in law and is not counted in the calculation of the percentage of shares voted "For" or "Against" any resolution or the total number of votes cast.

3. On 19 November 2025, the Company's issued share capital comprised 178,517,862 ordinary shares of 10 pence each (excluding treasury shares), 42,041 ordinary shares of 10 pence each held in treasury ('treasury shares') and 665,888,258 non-cumulative redeemable preference shares of 0.1 pence each ('B shares'). Each ordinary share of the Company carries one vote at General Meetings of the Company. Any ordinary shares held in treasury and the B shares have no voting rights. Consequently, on 19 November 2025, the total number of voting rights was 178,517,862.

4. Pursuant to UK Listing Rule 6.4.2, copies of all resolutions, other than those concerning ordinary business, passed at the AGM today will be submitted to the National Storage Mechanism and will shortly be available to view at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

5. Results of the poll will also be available shortly to view on the Company's website at www.mcbride.co.uk/investors/shareholder-information/agm/.

 

 

 

For further enquiries:

McBride plc

Robert Henry, General Counsel and Company Secretary

Chris Smith, Chief Executive Officer

 

0161 203 7401

Instinctif Partners

Hannah Scott

Galyna Kulachek

0207 457 2020

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMFLFVRLALIFIE
Date   Source Headline
12th Jun 20267:00 amRNSTrading and Acquisition Update
11th Jun 20261:44 pmRNSDirector/PDMR Shareholding
2nd Jun 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSTransaction in Own Shares
19th May 20267:00 amRNSTransaction in Own Shares
12th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSSecond tranche of share buyback programme
1st May 20267:00 amRNSTransaction in Own Shares
29th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSProposed Acquisition & Trading Conditions Update
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSDirector Appointment
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20266:28 pmRNSDirectorate change
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:05 amRNSInterim results for 6M ended 31 December 2025

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.